JAK1 and hyperinsulinemic hypoglycemia, familial, 4: Various genetic signals that may serve as predictive biomarkers, such as alterations in DNA damage response genes, MHC‐I genotypes, β‐2‐microglobulin deficiency, and Janus kinase 1/2 (JAK1/2) mutations, are being actively explored [16].